pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$NVONOVO NORDISK A S

$NVO37.32-0.21%
Bagsvaerd Denmark, DKupdated 6h ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
9
approvals ytd
4
recalls ytd
2

Pipeline(3)

pipeline depth3 products
Unknown: 3
3Unknown
drug
AWIQLI FLEXTOUCH
type 2 diabetes mellitus
Insulin receptor
drug
SOGROYA
1 INDICATIONS AND USAGE SOGROYA is indicated for the trea…
Growth hormone receptor
drug
VICTOZA
1 INDICATIONS AND USAGE VICTOZA is indicated: • as an adj…
Glucagon-like peptide 1 receptor

📅 Upcoming

Nov 4, 2026
earnings
$NVO37.32-0.21%
in 1mo
NOVO NORDISK A S earnings
NOVO NORDISK A S
→

🕒 Recent(90d)

earnings (1)
Aug 5, 2026
earnings
$NVO37.32-0.21%
2mo ago
NOVO NORDISK A S earnings
NOVO NORDISK A S
→
view all catalysts →
🐶 Hiring Signal
next earnings Nov 4, 2026
380 open roles at NOVO NORDISK A S →

Where NOVO NORDISK A S is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaMetabolic 30Cardiovascular 8Rare Disease 4CNS / Neuroscience 2Hematology 2
departmentIT & Engineering 30Manufacturing / CMC 26Commercial 24R&D / Discovery 17Business Development & Sales 14Supply Chain 13

News

no news has mentioned this company yet
identifiers
ticker
$NVO
SEC CIK
0000353278
country
DK
source
sec_tickers
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?